Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2002

01-08-2002

The Long Island Breast Cancer Study Project: Description of a Multi-Institutional Collaboration to Identify Environmental Risk Factors for Breast Cancer

Authors: Marilie D. Gammon, Alfred I. Neugut, Regina M. Santella, Susan L. Teitelbaum, Julie A. Britton, Mary Beth Terry, Sybil M. Eng, Mary S. Wolff, Steven D. Stellman, Geoffrey C. Kabat, Bruce Levin, H. Leon Bradlow, Maureen Hatch, Jan Beyea, David Camann, Martin Trent, Ruby T. Senie, Gail C. Garbowski, Carla Maffeo, Pat Montalvan, Gertrud S. Berkowitz, Margaret Kemeny, Marc Citron, Freya Schnabel, Allan Schuss, Steven Hajdu, Vincent Vincguerra, Gwen W. Collman, G. Iris Obrams

Published in: Breast Cancer Research and Treatment | Issue 3/2002

Login to get access
Metadata
Title
The Long Island Breast Cancer Study Project: Description of a Multi-Institutional Collaboration to Identify Environmental Risk Factors for Breast Cancer
Authors
Marilie D. Gammon
Alfred I. Neugut
Regina M. Santella
Susan L. Teitelbaum
Julie A. Britton
Mary Beth Terry
Sybil M. Eng
Mary S. Wolff
Steven D. Stellman
Geoffrey C. Kabat
Bruce Levin
H. Leon Bradlow
Maureen Hatch
Jan Beyea
David Camann
Martin Trent
Ruby T. Senie
Gail C. Garbowski
Carla Maffeo
Pat Montalvan
Gertrud S. Berkowitz
Margaret Kemeny
Marc Citron
Freya Schnabel
Allan Schuss
Steven Hajdu
Vincent Vincguerra
Gwen W. Collman
G. Iris Obrams
Publication date
01-08-2002
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/2002
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1016387020854

Other articles of this Issue 3/2002

Breast Cancer Research and Treatment 3/2002 Go to the issue

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine